Most importantly, both studies showed that treatment with FMT was able to induce favorable changes in the tumor microenvironment, including increases in CD8+ immune cell infiltrates, decreased frequency of IL-8-expressing immunosuppressive myeloid cells and favorable gene-expression profiles [113,114]. This evidence concerns the gene CD8A and neoplasm.